Immune System Diseases D007154

Diseases [C] » Immune System Diseases

Description

Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.   MeSH

Subtype Terms (11)

Autoimmune Diseases
133 drugs (85 approved, 48 experimental)

Erythroblastosis, Fetal
4 drugs (3 approved, 1 experimental)

Glomerulonephritis, Membranoproliferative
12 drugs (7 approved, 5 experimental)

Graft vs Host Disease
265 drugs (142 approved, 123 experimental)

Hypersensitivity
169 drugs (80 approved, 89 experimental)

Immune Reconstitution Inflammatory Syndrome
7 approved drugs

Immunologic Deficiency Syndromes
23 drugs (20 approved, 3 experimental)

Immunoproliferative Disorders
16 drugs (8 approved, 8 experimental)

Mast Cell Activation Disorders
3 experimental drugs

Purpura, Thrombocytopenic
8 drugs (7 approved, 1 experimental)

Transfusion Reaction
10 drugs (7 approved, 3 experimental)


Approved Indicated Drugs (1)


Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.